2026
13 Mar -
14 Mar
LONDON, UK
From 13-14th March 2026, IBSA Derma UK & Ireland makes its much-anticipated debut at ACE 2026, hosted at the Business Design Centre in London. This flagship event unites the brightest minds and boldest innovators in the non-surgical aesthetic arena, setting the stage for visionary dialogue and next-generation product launches.
IBSA Derma will take centre stage with a dedicated one-hour Symposium, crafted to inspire, educate, and elevate the industry. Further amplifying their presence, they proudly sponsor the Aesthetic Awards category: The IBSA Award for Best New Clinic, UK & Ireland, celebrating excellence and emerging talent.
A debut with purpose. A symposium that ignites ideas. An award that champions innovation. IBSA Derma UK & Ireland isn’t just entering the conversation - they’re shaping its future.
29 Jan -
31 Jan
PARIS, FRANCE
From 29 to 31 January 2026, the prestigious Palais des Congrès in Paris hosted the IMCAS World Congress, one of the leading global events in aesthetic medicine, dermatology, ageing science and plastic surgery. Over three days, world-renowned experts, leading physicians, researchers and industry pioneers gathered to present the latest innovations and take part in advanced theoretical and practical sessions.
As an ELITE Sponsor, IBSA Derma played a prominent role, reinforcing its commitment to innovation and excellence in regenerative aesthetic medicine. The brand contributed with a high-level symposium entitled Nahyco® Full Face: The New Frontier of Hybrid Regeneration. In addition, IBSA Derma hosted the Meet the Expert session, Regenerative Aesthetic Medicine: The Innovative Breakthrough of Nahyco® Technology, as well as a scientific session dedicated to the Aliaxin® filler range for natural aesthetic results.
At the same time, IBSA Derma took part in the IMCAS Industry Innovation Awards 2026 with PROFHILO® STRUCTURA, achieving an outstanding second-place recognition for excellence in regenerative aesthetic medicine innovation, further strengthening its position as a benchmark in the field.
The IMCAS World Congress programme also featured contributions from IBSA’s Chief Commercial Officer, Brand Manager and international Ambassadors. Through expert case presentations and round-table discussions, IBSA Derma addressed the evolving needs of patients worldwide, highlighting pioneering developments in regenerative aesthetic medicine.